Penumbra Inc (NYSE:PEN)
$ 186.94 -13.07 (-6.53%) Market Cap: 7.26 Bil Enterprise Value: 7.66 Bil PE Ratio: 549.82 PB Ratio: 6.25 GF Score: 82/100

Penumbra Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 06:15PM GMT
Release Date Price: $215.75 (+5.73%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Well, welcome, everybody. Long day. Hello. I'm Joanne Wuensch. I'm the medical technology analyst here at Citi. And thank you for joining this session. We have the management team of Penumbra, including the CEO, Adam Elsesser. Wow, long couple of days. So how are you?

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

I'm great and glad to be here. Thanks for having us.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Excellent. So I want to talk a little bit about the big picture of where you see Penumbra and where you see it going. You've become a little bit more specific in outlying the various categories that you're looking to drive revenue growth in or with. So just level set us.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Yes. So thank you sort of for asking it that way. We -- when we started the number all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot